Search - tctmd.com

Displaying 61 - 80 of 110

Sort: Relevancy | Date

News Daily News

止泻药洛哌丁胺的滥用与严重心脏事件包括死亡相关

Michael O'Riordan

June 08, 2016

News Daily News

Serious Cardiac Events, Including Death, Linked to Abuse of Antidiarrheal Medication Loperamide

Michael O'Riordan

June 08, 2016

News Daily News

Los Episodios Cardíacos Serios, incluida la Muerte se asocian a un Abuso del Fármaco Antidiarréico Lorepamida

Michael O'Riordan

June 08, 2016

News Daily News

US and European Heart Failure Guidelines Advocate Use of Two New Therapies

L.A. McKeown

May 24, 2016

News Daily News

遵循指南的急性心梗疗法可延缓疾病对死亡率的影响

Michael O'Riordan

May 17, 2016

News Daily News

La Adherencia a los Tratamientos de los IAM basados en las Directrices Tiene un Impacto Prolongado en las Tasas de Mortalidad

Michael O'Riordan

May 17, 2016

News Daily News

Adherence to Guideline-Based Acute MI Therapies Has Prolonged Impact on Mortality Rates

Michael O'Riordan

May 17, 2016

News Conference News ACC 2016

EARLY-BAMI: No Reduction in Infarct Size With IV Metoprolol Before Primary PCI

Caitlin E. Cox

April 03, 2016

News Opinion Editor's Corner

ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More

Shelley Wood

March 28, 2016

Presentation JIM 2016

Medical therapy optimization with new anti-ischemic drugs

Presenter: Giuseppe Musumeci

February 11, 2016

News Daily News

Signs of Cardioprotection Seen in Acute STEMI Patients Receiving IV Beta-blocker Post-PCI

Caitlin E. Cox

February 03, 2016

News Daily News

Se Observan Signos de Cardioprotección en Pacientes STEMI Agudos que Reciben Beta-Bloqueadores Post-PCI

Caitlin E. Cox

February 03, 2016

News Daily News

PCI 后接受 IV β 受体阻滞剂的急性 STEMI 患者中观察到心肌保护迹象

Caitlin E. Cox

February 03, 2016

Presentation

BEAT-AMI: Randomized Control of Sympathetic Drive With Continuous IV Esmolol in Patients With Acute STEMI

Presenter: Fikret Er

February 02, 2016

News Industry News

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

November 19, 2015

News Daily News

没有钱就得不到药物：全球范围内心血管疾病二级预防的障碍

Caitlin E. Cox

October 27, 2015

News Daily News

Sin Dinero Ni Medicamentos: Barreras Globales a la Prevención Secundaria de la Enfermedad Cardiovascular

Caitlin E. Cox

October 27, 2015

News Daily News

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Caitlin E. Cox

October 27, 2015

Presentation

Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-, Middle-, and Low-Income Countries

Presenter: R. Khatib

October 26, 2015

News Industry News

Laguna Pharmaceuticals Initiates Phase 3 Study of Vanoxerine in Atrial Fibrillation and Atrial Flutter

September 14, 2015

Advertisement

止泻药洛哌丁胺的滥用与严重心脏事件包括死亡相关

Serious Cardiac Events, Including Death, Linked to Abuse of Antidiarrheal Medication Loperamide

Los Episodios Cardíacos Serios, incluida la Muerte se asocian a un Abuso del Fármaco Antidiarréico Lorepamida

US and European Heart Failure Guidelines Advocate Use of Two New Therapies

遵循指南的急性心梗疗法可延缓疾病对死亡率的影响

La Adherencia a los Tratamientos de los IAM basados en las Directrices Tiene un Impacto Prolongado en las Tasas de Mortalidad

Adherence to Guideline-Based Acute MI Therapies Has Prolonged Impact on Mortality Rates

EARLY-BAMI: No Reduction in Infarct Size With IV Metoprolol Before Primary PCI

ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More

Medical therapy optimization with new anti-ischemic drugs

Signs of Cardioprotection Seen in Acute STEMI Patients Receiving IV Beta-blocker Post-PCI

Se Observan Signos de Cardioprotección en Pacientes STEMI Agudos que Reciben Beta-Bloqueadores Post-PCI

PCI 后接受 IV β 受体阻滞剂的急性 STEMI 患者中观察到心肌保护迹象

BEAT-AMI: Randomized Control of Sympathetic Drive With Continuous IV Esmolol in Patients With Acute STEMI

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

没有钱就得不到药物：全球范围内心血管疾病二级预防的障碍

Sin Dinero Ni Medicamentos: Barreras Globales a la Prevención Secundaria de la Enfermedad Cardiovascular

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-, Middle-, and Low-Income Countries

Laguna Pharmaceuticals Initiates Phase 3 Study of Vanoxerine in Atrial Fibrillation and Atrial Flutter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content